KLOW
Multi-Peptide Research Blend - Multi-peptide tissue-repair blend: KPV, GHK-Cu, TB-500 & BPC-157.
A comprehensive multi-peptide blend co-formulating several regenerative-research compounds, prepared for laboratories studying combined tissue-repair and barrier-function protocols.
The KLOW formulation is aimed at laboratories that want to study several regenerative mechanisms in a single, consistent preparation rather than reconstituting four compounds separately. It is best understood as a convenience blend for combination protocols, with the caveat that attributing any single effect to one component is not possible from the blend alone.
KLOW specifications
- Sequence
- KPV + Larazotide + GHK-Cu + BPC-157/TB-500
- Presentation
- Lyophilised powder
- Documented purity
- 99.71% by HPLC
- Available sizes
- 80mg ($140)
- Archived COA lots
- 3
- Intended use
- Laboratory research use only. Not for human or veterinary use.
Studied pathways
- Combined barrier & repair - Formulated for study of overlapping repair, anti-inflammatory and matrix pathways.
Reported mechanisms in the literature
- Combined barrier & repair - Formulated for study of overlapping repair, anti-inflammatory and matrix pathways across four regenerative-research compounds in a single protocol. (Combination research)
- Barrier-function research - Investigated for the interaction between anti-inflammatory tripeptide signalling and copper-peptide matrix remodelling alongside repair peptides. (Preclinical literature)
KLOW frequently asked questions
What is in the KLOW blend?
A co-formulation of KPV, GHK-Cu, BPC-157 and TB-500, prepared for laboratories studying combined tissue-repair and barrier-function protocols.
Is the blend approved for human use?
No. None of the components is approved for human use, and the blend is a research material only.
How is it documented?
The vial ships with a Certificate of Analysis for the combined lot.
Documented to 99.71% purity by HPLC · third-party COA every lot · from $140 · For laboratory research use only.
Related Regenerative & Repair compounds
- BPC-157 - Synthetic pentadecapeptide studied for VEGF and growth-factor receptor signalling.
- TB-500 - Thymosin β-4 fragment studied for actin regulation and tissue repair.
- BPC-157 / TB-500 - Co-formulated repair-research blend in a single vial.